HBIO (Harvard Bioscience) Cyclically Adjusted Book per Share: $21.02 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HBIO Harvard Bioscience Inc HBIO
53 GF Score
Price $8.06
GF Value $12.30
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Harvard Bioscience Cyclically Adjusted Book per Share?

Harvard Bioscience HBIO 53 Cyclically Adjusted Book per Share is $21.02 as of Jun. 2026. GuruFocus rates HBIO with a GF Score™ of 53/100 and a GF Value™ of $12.30 (Possible Value Trap). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Harvard Bioscience's adjusted book value per share for the three months ended in Jun. 2026 was $1.630. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $21.02 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Harvard Bioscience's average Cyclically Adjusted Book Growth Rate was -9.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -7.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -5.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Harvard Bioscience was 2.30% per year. The lowest was -7.90% per year. And the median was -1.35% per year.

As of today (2026-09-06), Harvard Bioscience's current stock price is $8.06. Harvard Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $21.02. Harvard Bioscience's Cyclically Adjusted PB Ratio of today is 0.38.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Harvard Bioscience was 2.91. The lowest was 0.13. And the median was 1.08.


Harvard Bioscience  (NAS:HBIO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Harvard Bioscience's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8.06/21.02
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Harvard Bioscience was 2.91. The lowest was 0.13. And the median was 1.08.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Harvard Bioscience Cyclically Adjusted Book per Share Related Terms


Harvard Bioscience Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Harvard Bioscience's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harvard Bioscience Cyclically Adjusted Book per Share Chart

Harvard Bioscience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.72 27.91 26.17 24.46 21.83

Harvard Bioscience Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.30 22.59 21.83 21.51 21.02

HBIO vs MLSS, FEMY, POCI: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Harvard Bioscience's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harvard Bioscience Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Harvard Bioscience's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Harvard Bioscience's Cyclically Adjusted PB Ratio falls into.


HBIO
53GF Score
Harvard Bioscience Inc HBIO
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harvard Bioscience Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Harvard Bioscience's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.63/333.9520*333.9520
=1.630

Current CPI (Jun. 2026) = 333.9520.

Harvard Bioscience Quarterly Data

Book Value per Share CPI Adj_Book
201609 22.081 241.428 30.543
201612 20.963 241.432 28.996
201703 21.004 243.801 28.771
201706 21.588 244.955 29.431
201709 22.048 246.819 29.831
201712 23.101 246.524 31.294
201803 22.236 249.554 29.756
201806 21.180 251.989 28.069
201809 21.711 252.439 28.722
201812 22.131 251.233 29.418
201903 21.318 254.202 28.006
201906 21.201 256.143 27.641
201909 20.258 256.759 26.348
201912 21.391 256.974 27.799
202003 19.804 258.115 25.623
202006 19.671 257.797 25.482
202009 19.802 260.280 25.407
202012 19.457 260.474 24.946
202103 19.303 264.877 24.337
202106 19.437 271.696 23.891
202109 18.840 274.310 22.936
202112 20.272 278.802 24.282
202203 18.520 287.504 21.512
202206 18.676 296.311 21.048
202209 17.278 296.808 19.440
202212 17.163 296.797 19.312
202303 17.620 301.836 19.495
202306 17.659 305.109 19.328
202309 17.401 307.789 18.880
202312 16.841 306.746 18.335
202403 15.848 312.332 16.945
202406 15.420 314.175 16.391
202409 14.975 315.301 15.861
202412 14.373 315.605 15.209
202503 3.356 319.799 3.505
202506 3.533 322.561 3.658
202509 3.156 324.800 3.245
202512 3.071 324.054 3.165
202603 2.227 330.213 2.252
202606 1.630 333.952 1.630

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $21.02 mean?
Harvard Bioscience (HBIO) has a Cyclically Adjusted Book per Share of $21.02 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Harvard Bioscience and its competitors.
Is Harvard Bioscience's Cyclically Adjusted Book per Share too high?
Harvard Bioscience's current Cyclically Adjusted Book per Share is $21.02. Overall, Harvard Bioscience has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Harvard Bioscience's Cyclically Adjusted Book per Share compare to MLSS and FEMY?
Harvard Bioscience's Cyclically Adjusted Book per Share of $21.02 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Harvard Bioscience and its competitors. Harvard Bioscience's current Cyclically Adjusted Book per Share is $21.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Harvard Bioscience (HBIO) is currently considered Possible Value Trap. The stock's GF Value™ is $12.30, compared to a current price of $8.06 — trading 34.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is $21.02. Harvard Bioscience's overall GF Score™ is 53/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Harvard Bioscience (HBIO), the current Cyclically Adjusted Book per Share is $21.02 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harvard Bioscience (HBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Harvard Bioscience stock appears to be undervalued. The current stock price of $8.06 is trading 34.5% below its estimated GF Value™ of $12.30. GuruFocus considers Harvard Bioscience to be Possible Value Trap.

Key valuation signals for HBIO:

  • Cyclically Adjusted Book per Share: $21.02
  • GF Value™: $12.30 vs. price of $8.06 (34.5% below fair value)
  • GF Score™: 53/100 with 9 warning signs

No single metric tells the full story. See the HBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Harvard Bioscience Business Description

Address 84 October Hill Road, Suite 10, Holliston, MA, USA, 01746
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
53GF Score

Get the complete analysis for HBIO

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.06
Price
$12.30
GF Value